@article{JTD22530,
author = {Sharaf-Eldin Shehada and Daniel Wendt and Davina Peters and Fanar Mourad and Philipp Marx and Matthias Thielmann and Philipp Kahlert and Alexander Lind and Rolf-Alexander Janosi and Tienush Rassaf and Peter-Michael Rath and Martin Thoenes and Heinz Jakob and Mohamed El Gabry},
title = {Infections after transcatheter versus surgical aortic valve replacement: mid-term results of 200 consecutive patients},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {7},
year = {2018},
keywords = {},
abstract = {Background: Transcatheter aortic valve implantation (TAVI) is the standard therapy for high-risk patients with aortic stenosis (AS). TAVI-outcomes are widely investigated in comparison to surgical aortic valve replacement (SAVR), but less is known about infectious complications after TAVI. We aimed to compare early and mid-term infectious outcomes of patients undergoing TAVI or SAVR.
Methods: The present study is a prospective single-centre study including 200 consecutive patients between 06/2014–03/2015 undergoing TAVI (either transfemoral or transapical and transaortic, n=47+53=100) or SAVR (either isolated or concomitant with CABG, n=52+48=100). The mean age and log. EuroSCORE were significantly different between both groups (81±6 versus 69±11 years, P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/22530}
}